• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌蛋白P75gag-v-erbA仅通过含有回文半位点的反应元件抑制甲状腺激素诱导的转录。

The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.

作者信息

Wahlström G M, Harbers M, Vennström B

机构信息

Department of Cellular and Molecular Biology, Karolinska Institute, Stockholm, Sweden.

出版信息

Oncogene. 1996 Aug 15;13(4):843-52.

PMID:8761306
Abstract

The v-erbA oncoprotein P75gag-v-erbA, derived from the thyroid hormone receptor alpha (TR alpha), functions as a transdominant transcriptional repressor. The mechanism by which P75gag-v-erbA acts is however poorly characterized. Here, we show that repression of TR alpha mediated transcription by P75gag-v-erbA in transformed erythroblasts is dependent on the structure of the thyroid hormone response element to which it binds. A very efficient repression was seen with hormone response elements having half-sites organized as everted repeats (ER), whereas repression was inefficient with directly repeated half-sites (DR). Promoters containing half-sites organized as an inverted palindrome (IR) gave an intermediate repression. Although P75gag-v-erbA failed to associate with the ligand binding domain of retinoid X (RXR) receptor in a two-hybrid test, the oncoprotein in nuclear extracts from transformed cells heterodimerised quantitatively with RXR upon binding to response elements of the DR type. On the other hand, both RXR/P75gag-v-erb heterodimers and other types of dimers formed on ER elements. P75gag-v-erbA also failed to bind to elements that contained only one half-site in vivo and in vitro. The data demonstrate that P75gag-v-erbA represses gene expression efficiently as a dimer, and suggest that thyroid hormone responsive genes that may be targets for the action of the oncoprotein are repressed most efficiently if they contain elements of the ER type.

摘要

源自甲状腺激素受体α(TRα)的原癌蛋白P75gag-v-erbA作为一种反式显性转录抑制因子发挥作用。然而,P75gag-v-erbA发挥作用的机制目前还不清楚。在此,我们表明,在转化的成红细胞中,P75gag-v-erbA对TRα介导的转录的抑制作用取决于它所结合的甲状腺激素反应元件的结构。对于具有反向重复排列半位点(ER)的激素反应元件,观察到非常有效的抑制作用,而对于直接重复排列的半位点(DR),抑制作用效率较低。含有反向回文排列半位点(IR)的启动子产生中等程度的抑制作用。虽然在双杂交试验中P75gag-v-erbA未能与视黄酸X(RXR)受体的配体结合域结合,但在与DR型反应元件结合后,来自转化细胞的核提取物中的原癌蛋白能与RXR定量异源二聚化。另一方面,RXR/P75gag-v-erb异源二聚体以及在ER元件上形成的其他类型的二聚体均有出现。P75gag-v-erbA在体内和体外也未能与仅含有一个半位点的元件结合。这些数据表明,P75gag-v-erbA作为二聚体可有效抑制基因表达,并表明如果甲状腺激素反应性基因含有ER型元件,那么它们作为原癌蛋白作用的靶点可能会被最有效地抑制。

相似文献

1
The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.癌蛋白P75gag-v-erbA仅通过含有回文半位点的反应元件抑制甲状腺激素诱导的转录。
Oncogene. 1996 Aug 15;13(4):843-52.
2
Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.癌蛋白P75gag-v-erbA和甲状腺激素受体对维甲酸X受体的抑制作用要求
Mol Endocrinol. 1998 May;12(5):645-53. doi: 10.1210/mend.12.5.0096.
3
A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.甲状腺激素反应性半位点中的一个核苷酸决定了v-erbA癌蛋白在转录增强与抑制之间的选择。
Oncogene. 2000 Jul 27;19(32):3563-9. doi: 10.1038/sj.onc.1203692.
4
V-erbA requires auxiliary proteins for dominant negative activity.V-erbA发挥显性负性活性需要辅助蛋白。
Oncogene. 1993 Jan;8(1):55-65.
5
c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.c-ErbA而非v-ErbA与一种假定的红系阻遏物竞争结合碳酸酐酶II启动子。
Oncogene. 1994 Oct;9(10):2853-67.
6
Dimerization of v-erbA on inverted repeats.v-erbA在反向重复序列上的二聚化。
Biochem Biophys Res Commun. 2002 May 31;294(1):35-41. doi: 10.1016/S0006-291X(02)00428-X.
7
Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.v-ErbA癌蛋白导致的白血病转化在体内需要与红系增强子持续结合并对其进行抑制。
EMBO J. 1998 Dec 15;17(24):7382-94. doi: 10.1093/emboj/17.24.7382.
8
Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.v-ErbA介导的转化机制:在自我更新诱导中替代类固醇激素受体功能。
Oncogene. 1997 Aug 7;15(6):701-15. doi: 10.1038/sj.onc.1201208.
9
The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.v-ErbA癌蛋白可抑制红系特异性增强子的活性。
Oncogene. 2001 Feb 15;20(7):775-87. doi: 10.1038/sj.onc.1204159.
10
Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.V-erbA癌蛋白(甲状腺激素受体α的病毒同源物)DNA结合位点的鉴定。
J Steroid Biochem Mol Biol. 1998 Nov;67(3):181-91. doi: 10.1016/s0960-0760(98)00100-9.

引用本文的文献

1
The adenoviral E1A protein displaces corepressors and relieves gene repression by unliganded thyroid hormone receptors in vivo.腺病毒E1A蛋白在体内取代共抑制因子并解除未结合配体的甲状腺激素受体对基因的抑制作用。
Cell Res. 2009 Jun;19(6):783-92. doi: 10.1038/cr.2009.55.
2
Multiple mutations contribute to repression by the v-Erb A oncoprotein.多种突变导致v-Erb A癌蛋白发挥抑制作用。
Oncogene. 2005 Oct 13;24(45):6737-52. doi: 10.1038/sj.onc.1208826.